The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 5.00 (0.29%)
Spread: 0.50 (0.029%)
Open: 1,733.00
High: 1,739.50
Low: 1,724.50
Prev. Close: 1,728.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London close: BG Group drags FTSE 100 lower, Syria concerns weigh

Mon, 09th Sep 2013 17:44

The FTSE 100 dropped into the red on Monday, pulling back after hitting a three-week high the previous session, as heavy falls from natural gas giant BG Group and ongoing concerns about Syria pressured stocks lower.London's benchmark index finished 16.59 points lower at 6,530.74, falling 0.25% from Friday's close of 6,547.33 which was its highest closing price since August 14th.Syria continues to be in focus this week ahead of a vote by US Congress over whether or not to proceed with a military attack after last month's alleged use of chemical weapons by Bashar Al-Assad's regime. Tensions at the G20 Summit escalated last week after Vladimir Putin said Russia would "assist" Syria if it was attacked by the US, just as President Barack Obama was trying to rally for support from global leaders for an intervention.Talks between US Secretary of State John Kerry and UK Foreign Secretary William Hague also caught the headlines this morning after Hague said the objectives and efforts of the US and UK "remain closely aligned". Kerry said that the relationship between the two countries was not affected by the UK's decision not engage in a military attack, but said that "the risk of not acting is greater than the risk of acting"."Despite the UK watching the Syria affair from the side-lines after the Prime Minister failed to secure parliamentary support for action, fallout from this vote will still be felt in the UK markets with oil prices and a potential flight to quality affecting both equity and Gilts," said Financial Sales Trader Alex Conroy.Uncertainty regarding Federal Reserve monetary policy also prompted traders to adopt a cautious approach in the aftermath of Friday's disappointing jobs report. A worse-than-expected rise in non-farm payrolls in August sparked speculation that the US central bank could hold off from tapering its quantitative easing (QE) programme until later on in the year. However, the unemployment rate fell last month from 7.4% to 7.3%.Chinese exports rise, Japan GDP revised upAsian markets performed well overnight after Chinese trade and inflation numbers brightened the third-quarter outlook for the world's second-largest economy. Chinese exports rose by a stronger-than-expected 7.2% in August and imports jumped by 7%, while the annual rate of consumer price inflation eased from 2.7% to 2.6%. Writing in Monday's Financial Times Chinese Premier Li Keqiang said that his country will stay the course on sustainable growth, by continuing to promote reforms, with an aim of meeting its 7.5% lower bound for gross domestic product (GDP) growth this year. Meanwhile, second-quarter GDP estimates in Japan were revised higher from 0.6% to 0.9%, as confidence grows in Prime Minister Shinzo Abe's so-called 'Abenomics'. While this was slightly lower than predictions, this data - along with the news that Tokyo will host the 2020 Olympics - gave the Nikkei 225 index a strong boost.FTSE 100: BG drops after cutting production guidanceOil and gas group BG was a heavy faller after lowering its 2014 production milestones due to the instability in Egypt, delays to the start-up of production in Norway and low natural gas prices in the US.Sugar and food group Tate & Lyle wasn't far behind after UBS downgraded the stock from 'neutral' to 'sell', saying that its current valuation is too high and does not reflect that "sucralose prices continue to decline as 'generic' competitors improve product quality and access greater scale".Food ingredients peer and retail group Associated British Foods was also lower despite saying a strong finish to the year from Primark will help it deliver adjusted operating profit ahead of expectations for the second half. Instead, the market was focusing on comments about low EU sugar prices next year.Mining stocks were putting in a mixed performance despite the strong data from top metals user China. Analysts at Citigroup said today that mining stocks could benefit from "additional short-term price momentum in the sector on positive rhetoric" following the category's underperformance so far this year compared with the UK market. "However, valuations are now looking more fully priced and we think the rally will fade into year end." The bank named Rio Tinto and Glencore Xstrata as its favoured stocks in the UK diversified mining sector, both of which were making gains today.GlaxoSmithKline declined after confirming it has reached an agreement to sell its Lucozade and Ribena brands to Japanese firm Suntory Beverage & Food for £1.35bn in cash. The company said that now is the right time to sell "as we increase the focus of our Consumer Healthcare business and execute the delivery of our late stage pipeline of pharmaceuticals and vaccines".FTSE 250: Icap and CSR lead gainsICAP is in talks about a settlement over its role in the Libor rate-rigging scandal which could see it pay about £70m ($109m) to British and US regulators, Sky News reported.Broker Liberum lited its target on CSR to buy, with a 550p price target. FTSE 100 - RisersARM Holdings (ARM) 917.50p +2.80%TUI Travel (TT.) 347.40p +2.72%Aviva (AV.) 399.80p +2.25%Burberry Group (BRBY) 1,635.00p +2.19%Lloyds Banking Group (LLOY) 76.78p +1.82%Kingfisher (KGF) 413.20p +1.67%ITV (ITV) 177.40p +1.66%Legal & General Group (LGEN) 193.80p +1.63%Whitbread (WTB) 3,216.00p +1.55%British Land Co (BLND) 557.50p +1.46%FTSE 100 - FallersBG Group (BG.) 1,217.00p -5.07%Tate & Lyle (TATE) 779.50p -3.41%Associated British Foods (ABF) 1,818.00p -1.78%Randgold Resources Ltd. (RRS) 4,914.00p -1.50%Petrofac Ltd. (PFC) 1,397.00p -1.34%Royal Dutch Shell 'A' (RDSA) 2,052.00p -1.27%Standard Chartered (STAN) 1,455.50p -1.12%United Utilities Group (UU.) 673.00p -1.10%Tullow Oil (TLW) 1,059.00p -1.03%HSBC Holdings (HSBA) 701.10p -1.02%FTSE 250 - RisersICAP (IAP) 417.80p +4.58%CSR (CSR) 517.50p +4.55%Barratt Developments (BDEV) 328.20p +4.36%888 Holdings (888) 146.90p +4.18%Enterprise Inns (ETI) 150.40p +3.72%Perform Group (PER) 523.50p +3.66%Bank of Georgia Holdings (BGEO) 1,810.00p +3.13%Debenhams (DEB) 104.50p +2.96%Halfords Group (HFD) 393.70p +2.79%Computacenter (CCC) 538.00p +2.77%FTSE 250 - FallersXaar (XAR) 760.00p -4.34%Petra Diamonds Ltd.(DI) (PDL) 122.90p -3.46%Salamander Energy (SMDR) 125.00p -3.40%Berendsen (BRSN) 906.50p -2.89%Bumi (BUMI) 211.20p -2.85%Kenmare Resources (KMR) 28.36p -2.54%Workspace Group (WKP) 430.60p -2.36%BTG (BTG) 368.00p -2.34%Brown (N.) Group (BWNG) 557.00p -2.28%Imagination Technologies Group (IMG) 287.10p -2.18%BC
More News
17 Dec 2023 15:16

PRESS: GSK looks for deals in China as rebuilds relationship

(Alliance News) - The Financial Times on Sunday reported that GSK PLC is looking for some new deals in China.

Read more
15 Dec 2023 17:08

European shares end fifth week higher on rate-cut optimism

Barclays sees first ECB rate cut in April

*

Read more
15 Dec 2023 16:51

LONDON MARKET CLOSE: FTSE 100 underperforms as post-Fed rally cools

(Alliance News) - London's FTSE 100 ended lower on Friday, with profit-taking and some hawkish words from a US policymaker keeping equities in check at the end of a largely positive week for stocks.

Read more
15 Dec 2023 16:29

PRESS: GSK, Astra and AbbVie in US scrutiny over patents - Bloomberg

(Alliance News) - A US senator has accused AstraZeneca PLC, GSK PLC, AbbVie Inc and other drugmakers of "abusing" the patent system to send prices higher, Bloomberg reported on Thursday.

Read more
12 Dec 2023 10:08

AstraZeneca buys respiratory vaccine developer Icosavax in $1.1 bln deal

Dec 12 (Reuters) - AstraZeneca said on Tuesday it had agreed to buy respiratory syncytial virus (RSV) vaccine developer Icosavax in a deal valued at up to $1.1 billion.

Read more
12 Dec 2023 08:22

TOP NEWS: Japan accepts GSK's filing for respiratory disease vaccine

(Alliance News) - GSK PLC on Tuesday said Japan's Ministry of Health, Labour & Welfare has accepted its regulatory application for the extension of its respiratory syncytial virus vaccine, Arexvy, for adults aged 50-59.

Read more
12 Dec 2023 07:39

LONDON BRIEFING: UK unemployment unchanged at 4.2%; eyes on US CPI

(Alliance News) - Stocks in London are called to open higher, as investors digest the latest UK unemployment data, before turning their heads to US inflation.

Read more
12 Dec 2023 07:24

GSK seeks to extend RSV vaccine approval in Japan

(Sharecast News) - GSK announced on Tuesday that Japan's Ministry of Health, Labour and Welfare (MHLW) has accepted its regulatory application for the extension of the indication of its RSV vaccine to include adults aged 50- to 59 at an increased risk of contracting the disease.

Read more
11 Dec 2023 08:28

GSK drug gets EU marketing backing for form of endometrial cancer

(Alliance News) - GSK PLC on Monday said it won EU backing for its Jemperli drug in tandem with chemotherapy to treat a form of endometrial cancer.

Read more
11 Dec 2023 07:41

LONDON BRIEFING: GSK drug gets EU endorsement; Begbies backs outlook

(Alliance News) - London's FTSE 100 is called to open a touch lower on Monday, kicking off the week with some slight trepidation after Friday's hotter-than-expected US jobs report which offered the dollar some respite.

Read more
11 Dec 2023 07:23

GSK endometrial cancer treatment gets Europe authorisation

(Sharecast News) - GSK announced on Monday that the European Commission has granted marketing authorisation for 'Jemperli', or dostarlimab, in combination with chemotherapy for certain endometrial cancers.

Read more
7 Dec 2023 12:54

THG backer Kelso pushes for demerger to trim "inherent" valuation gap

(Alliance News) - THG PLC investor Kelso Group Holdings PLC on Thursday reiterated its call for a demerger, which the shareholder believes will help close the "disparity" between the e-commerce firm's share price and its true value.

Read more
5 Dec 2023 10:02

LONDON BROKER RATINGS: Goldman lifts Landsec and British Land

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
27 Nov 2023 09:00

GSK announces positive results from Blenrep phase 3 blood cancer trial

(Alliance News) - GSK PLC on Monday said a phase 3 trial of belantamab mafodotin as a multiple myeloma treatment has produced positive headline results.

Read more
27 Nov 2023 08:02

GSK receives 'positive' headline results from phase III trial

(Sharecast News) - Drugmaker GSK announced on Monday that it had received positive headline results from a planned interim efficacy analysis from a phase III trial evaluating its elantamab mafodotin asset.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.